Summary

Argireline (acetyl hexapeptide-8, formerly acetyl hexapeptide-3) is a synthetic neuropeptide used in cosmetic research to reduce expression-line wrinkles. It inhibits SNARE complex formation and catecholamine release, partially reducing muscle contraction at the skin surface. Evidence is primarily from in vitro and small clinical studies. For research and educational purposes only.

Mechanism

Argireline (acetyl hexapeptide-8) mimics the N-terminal end of SNAP-25, a protein component of the SNARE complex required for synaptic vesicle fusion and neurotransmitter release. By interfering with SNARE complex assembly, Argireline partially inhibits the release of acetylcholine and catecholamines at the neuromuscular junction. This attenuates muscle contraction, reducing the repetitive folding of skin that causes expression lines. The mechanism is similar to botulinum toxin but substantially milder and limited by topical bioavailability.

Evidence base

Evidence Grade: Limited

Key findings:

  • SNARE complex inhibition demonstrated in vitro, reducing neurotransmitter release (Blanes-Mira et al., 2002)
  • 30% reduction in wrinkle depth after 30 days of 10% topical formulation (small clinical study, n=10)
  • Catecholamine release inhibition with IC50 ~30 μM in chromaffin cells

Limitations: Very small clinical studies, often industry-funded (Lipotec/Lubrizol), no large-scale independent trials. Effect magnitude is modest compared to injectable botulinum toxin.

Protocols

Argireline is formulated topically at 5–10% concentration in cosmetic preparations, applied once or twice daily to expression-line areas. Effects observed over 2–4 weeks; reversible upon discontinuation. Not administered by injection. Not medical advice.

Argireline is a cosmetic ingredient, not a licensed medicine. It is legal to purchase, possess, and use in cosmetic formulations in the UK. It is regulated under UK cosmetic regulations (Cosmetic Products Enforcement Regulations 2013) rather than MHRA pharmaceutical regulations.

Vendor notes

Argireline is widely available from cosmetic ingredient suppliers. For research-grade material, look for suppliers providing certificates of analysis confirming peptide identity and purity (≥98%).

References

  1. Blanes-Mira C, et al. "A synthetic hexapeptide (Argireline) with antiwrinkle activity." International Journal of Cosmetic Science. 2002. DOI: 10.1046/j.1467-2494.2002.00110.x
  2. Schagen SK. "Topical peptide treatments with effective anti-aging results." Cosmetics. 2017. DOI: 10.3390/cosmetics4020016
  3. Gorouhi F, Maibach HI. "Role of topical peptides in preventing or repairing aged skin." International Journal of Cosmetic Science. 2009. DOI: 10.1111/j.1468-2494.2009.00490.x
  4. Lubrizol/Lipotec. "Argireline solution technical data sheet." Industry data — used for formulation context only.